Abstract Glomerulopathies are one of the leading causes of end-stage renal disease. In the last years, clinical research has made significant contributions to the understanding of such conditions. Rec
Glomerular diseases (GDs) represent the third leading cause of end stage kidney disease (ESKD) in the U.S.. Diabetes was excluded from the CureGN Study, an NIH/NIDDK-sponsored observational cohort stu
